Glen L. Stimmel has had a distinguished career in pharmacy.
“Challenging the status quo leads to very good things,” said Glen L. Stimmel, PharmD ’72, who has spent a career doing just that. As a motto, it has served him, and his profession, quite well.
Mary Anne Koda-Kimble, PharmD, former dean of the School of Pharmacy
The 2019 Mary Anne Koda-Kimble Seed Award for Innovation will fund nine bold research projects, ranging from studies of the molecular underpinnings of cancer to focus groups designed to prepare PharmD students for experiential learning.
Deanna Kroetz, PhD (right) was among dozens of faculty members who contributed to the School of Pharmacy becoming the top recipient of NIH funding among all pharmacy schools in 2018.
Among all U.S. pharmacy schools, the UCSF School of Pharmacy earned the most research funding from the National Institutes of Health in 2018, totaling nearly $29 million dollars that will support studies spanning the basic to the clinical sciences.
Clinically, I work as a Critical Care Pharmacist practicing in the Medical/Surgical Intensive Care Units at UCSF Medical Center. My interests in improvement work and high value care led me to a role in the Medication Outcomes Center where I conduct research and quality improvement work. My specific research interests are in pain, agitation, and delirium management and the role of technology in promoting safe and appropriate medication use. I am particularly interested in how we can use the electronic health record (EHR) to increase the adoption of best practices and collaborate with others in the medical center to operationalize new medication therapies and decision support within our EHR.
We will explore the current research and demonstrate and practice resiliency building tools including a cross-section of mind-body interactions and internal narratives (story telling). Course completion requires teaching and modeling resiliency skills. Those who successfully complete the training will be awarded a certificate in resiliency training.
Bani Tamraz, PharmD, PhD, is the featured Pharmacogenomics Research Network Investigator (PGRN) for February 2019. An article on the group’s website describes his overall goal to build a patient-oriented program of pharmacogenetics research, teaching, and clinical practice that utilizes genetics for therapy optimization at UCSF and beyond. Read the full article here: Featured PGRN Investigators
